Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Daiichi Sankyo
Daiichi Sankyo
Daiichi Sankyo, AstraZeneca collaborate to evaluate patritumab deruxtecan in combination with TAGRISSO in EGFR-mutated NSCLC
Pharmaceutical Business Review
Fri, 08/7/20 - 11:10 am
Daiichi Sankyo
AstraZeneca
patritumab deruxtecan
Tagrisso
non-small cell lung cancer
clinical trials
4 Reasons AstraZeneca Gave Daiichi Sankyo Another $1 Billion Upfront
Motley Fool
Tue, 07/28/20 - 11:14 am
AstraZeneca
DS-1062
Daiichi Sankyo
AstraZeneca inks $6bn cancer drug deal with Daiichi Sankyo
Pharmaforum
Mon, 07/27/20 - 11:00 am
AstraZeneca
Daiichi Sankyo
DS-1062
antibodies
cancer
Daiichi Sankyo expands DS-1062 study to include patients with triple negative breast cancer
Pharmaceutical Business Review
Thu, 07/2/20 - 11:09 am
Daiichi Sankyo
antibody-drug conjugate
triple negative breast cancer
DS-1062
clinical trials
AstraZeneca, Daiichi Sankyo working on Japanese supply deal for COVID-19 vaccine hopeful
Fierce Pharma
Fri, 06/26/20 - 01:04 pm
AstraZeneca
Daiichi Sankyo
University of Oxford
vaccines
COVID-19
Japan
Daiichi Sankyo and Thermo Fisher Partner on Companion Diagnostic Device for NSCLC
BioSpace
Tue, 06/23/20 - 11:39 pm
Daiichi Sankyo
Thermo Fisher
companion diagnostics
diagnostics
non-small cell lung cancer
ASCO data back AZ/Daiichi Sankyo’s Enhertu in new HER2 cancers
Pharmaforum
Sat, 05/30/20 - 08:04 pm
Daiichi Sankyo
AstraZeneca
Enhertu
stomach cancer
colorectal cancer
lung cancer
ASCO 2020
AZ/Daiichi’s Enhertu gains second ‘breakthrough’ tag in space of a week
Pharmaforum
Mon, 05/18/20 - 10:49 am
AstraZeneca
Daiichi Sankyo
Enhertus
metastatic non-small-cell lung cancer
AstraZeneca, Daiichi Sankyo get FDA breakthrough therapy status for gastric cancer drug
Pharmaceutical Business Review
Mon, 05/11/20 - 10:27 am
AstraZeneca
Daiichi Sankyo
FDA
Enhertu
gastric cancer
breakthrough therapy
Daiichi Sankyo submits application for CAR T therapy axicabtagene ciloleucel to treat patients with certain relapsed/refractory B-cell lymphomas in Japan
Pharmaceutical Business Review
Tue, 03/31/20 - 11:05 am
Daiichi Sankyo
Japan
CAR-T
axicabtagene ciloleucel
relapsed or refractory diffuse large B-cell lymphoma
Astra, Daiichi's Enhertu shows early promise in HER2 lung cancer
Fierce Biotech
Wed, 03/25/20 - 10:49 am
AstraZeneca
Daiichi Sankyo
Enhertu
clinical trials
HER2-positive non-small cell lung cancer
AZ, Daiichi’s new cancer drug Enhertu gets off to the races with quick U.S. launch
Fierce Pharma
Mon, 02/10/20 - 11:42 pm
AstraZeneca
Daiichi Sankyo
clinical trials
FDA
Enhertu
cancer
breast cancer
Antibody-drug conjugates on the march
Pharmaforum
Thu, 01/30/20 - 10:41 am
antibody-drug conjugate
AstraZeneca
Daiichi Sankyo
Enhertu
Breast cancer approval in tow, AstraZeneca, Daiichi armed antibody scores in key gastric cancer study
Endpoints
Mon, 01/27/20 - 10:44 am
AstraZeneca
breast cancer
Daiichi Sankyo
trastuzumab deruxtecan
gastric cancer
FDA hastily approves Daiichi Sankyo/AZ’s cancer drug, weeks after US filing
Pharmaforum
Mon, 12/23/19 - 11:46 pm
FDA
AstraZeneca
Daiichi Sankyo
advanced breast cancer
Enhertu
Daiichi, AstraZeneca breast cancer drug joins bumper crop of early FDA approvals
BioPharma Dive
Fri, 12/20/19 - 08:19 pm
Daiichi Sankyo
AstraZeneca
FDA
drug approvals
breast cancer
trastuzumab deruxtecan
SABCS 2019 – Astrazeneca and Daiichi join the Her2 resistance
EP Vantage
Wed, 12/11/19 - 10:24 am
breast cancer
AstraZeneca
Daiichi Sankyo
SABCS
trastuzumab deruxtecan
Seattle Genetics Claims Arbitration Rights in Daiichi Sankyo ADC Dispute
BioSpace
Tue, 12/3/19 - 10:29 pm
Seattle Genetics
Daiichi Sankyo
antibody-drug conjugate
Eyeing second Japanese approval, Daiichi and Exelixis announce positive pivotal for kidney drug
Endpoints
Fri, 11/8/19 - 10:40 am
Daiichi Sankyo
Exelixis
clinical trials
diabetic nephropathy
Minnebro
Daiichi Sankyo takes Seattle Genetics to court as battle over breast cancer drug escalates
Pharmaforum
Wed, 11/6/19 - 10:18 am
Daiichi Sankyo
Seattle Genetics
breast cancer
AstraZeneca
trastuzumab deruxtecan
Herceptin
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »